< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. Genazzani AR, et al. "Hormone fluctuations and symptom variability in perimenopause." Gynecological Endocrinology. 2021.
  2. Harlow SD, et al. "Executive Summary of the Stages of Reproductive Aging Workshop +10: Addressing the Unfinished Agenda of Staging Reproductive Aging." Journal of Clinical Endocrinology & Metabolism. 2012;97(4):1159–1168. (STRAW+10 staging criteria)
  3. Santoro N, et al. "Menopausal symptoms and their management." Endocrinology and Metabolism Clinics of North America. 2015;44(3):497–515.
  4. Prior JC. "Progesterone for symptomatic perimenopause treatment." Journal of Obstetrics and Gynaecology Canada. 2011;33(12):1236–1238.
  5. Stanczyk FZ. "All progestins are not created equal." Steroids. 2003;68(10-13):879–890. (Context: metabolite differences in hormone measurement)
  6. Precision Analytical. "DUTCH Complete Test: Interpretive Guide." precision-analytical.com.
  7. Oova. "Lab-grade hormone validation data." oova.life. (99% accuracy vs. blood test, developed by Mount Sinai physicians.)

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.